1. Amor B, Dougados M, Mijiyawa M (1990) Criteria of the classifcation of spondylarothpathies. Rev Rheum Mal Osteoartic 57:85–89
2. Bennett W (1968) Population studies of the rheumatic disease. Excerpta Medica, New York, S 4–6
3. Brooks CD (2001) Sulfasalazine for the management of juvenile rheumatoid arthritis. J Rheumatol 28:845–853
4. Cassidy JT, Petty RE (2001) Juvenile ankylosing spondylitis. In: Cassidy JT, Petty RE (Hrsg) Textbook of pediatric rheumatology. Saunders, Philadelphia, S 323–345
5. Foeldvari I, Constantin T, Vojinović J, Horneff G, Chasnyk V, Dehoorne J, Panaviene V, Sušić G, Stanevicha V, Kobusinska K, Zuber Z, Dobrzyniecka B, Nikishina I, Bader-Meunier B, Breda L, Doležalová P, Job-Deslandre C, Rumba-Rozenfelde I, Wulffraat N, Pedersen RD, Bukowski JF, Vlahos B, Martini A, Ruperto N, Paediatric Rheumatology International Trials Organisation (PRINTO) (2019) Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial. Arthritis Res Ther 21(1):125. https://doi.org/10.1186/s13075-019-1916-9